A private equity-backed deal to take ShangPharma Corp. private for $173 million has closed.

ShangPharma is a China-based contract-research organization that does chemical, pharmaceutical, biological and other research. The deal was announced in December.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.